SEC 13F Intelligence

Aquilo Capital Management, LLC / GMAB

Aquilo Capital Management, LLC’s Genmab A/S Position

Does Aquilo Capital Management, LLC own Genmab A/S (GMAB)? Not currently — the last reported position was 52.1K shares worth $2M in Q3 2023; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$2M
Q3 2023
Shares
52.1K
% of Portfolio
+1.67%
Quarters Held
13
position exited

Position History GMAB

Reported value by quarter
Q3 ’20: $2MQ3 ’20Q4 ’20: $4MQ1 ’21: $4MQ1 ’21Q2 ’21: $5MQ3 ’21: $6MQ3 ’21Q4 ’21: $5MQ1 ’22: $6MQ1 ’22Q2 ’22: $7MQ3 ’22: $8MQ3 ’22Q4 ’22: $10MQ1 ’23: $9MQ1 ’23Q2 ’23: $7MQ3 ’23: $2MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202352.1K$2M+1.67%
Q2 2023174.6K$7M+3.68%
Q1 2023242.8K$9M+3.80%
Q4 2022242.8K$10M+3.87%
Q3 2022244.8K$8M+2.84%
Q2 2022214.8K$7M+2.38%
Q1 2022167.5K$6M+0.89%
Q4 2021127.5K$5M+0.57%
Q3 2021127.5K$6M+1.01%
Q2 2021120.0K$5M+1.27%
Q1 2021120.0K$4M+0.71%
Q4 202090.0K$4M+0.76%
Q3 202050.0K$2M+0.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Aquilo Capital Management, LLC’s full portfolio or all institutional holders of GMAB.